Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Ted Snelgrove, Bernard Sixt, Nicolas Pasqual, Keith Brownlie


Cellscape has named Ted Snelgrove as its new CEO.

Snelgrove joins the prenatal genetic testing firm from Crescendo Bioscience, where he served as chief commercial officer. He also worked previously at Genomic Health, where he was vice president of sales and marketing.

Bernard Sixt has joined ImmunID as its new president and CEO.

Sixt was CEO of Agendia from 2003 to 201. He takes over the CEO position from ImmunID cofounder Nicolas Pasqual, who will continue on as the company's chief scientific officer.

Cancer Genetics has named Keith Brownlie to its board of directors and to its audit committee. Brownlie has served as the audit partner for a number of life sciences companies, including Epicet and Rxi Pharmaceuticals.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.